Prudential Financial’s Trillium Therapeutics Inc. TRIL Stock Holding History

Prudential Financial’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,007	Closed	-$193K	–	2738
2021 Q3	$193K	Buy	+11,007	New	+$129K	﹤0.01%	2483

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Prudential Financial's TRIL Position: Q4 2021 in Review

Prudential Financial sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 11,007 shares — an estimated $193K sold.

Prudential Financial first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $193K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Prudential Financial reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Prudential Financial sold 11,007 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $193K.
Prudential Financial first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Prudential Financial's Trillium Therapeutics Inc. position peaked at $193K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Prudential Financial's 13F filing for Q4 2021, filed 14 Feb 2022.